Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 718201, 5 pages
http://dx.doi.org/10.1155/2015/718201
Research Article

The Prevalence of Autoantibodies in Complex Regional Pain Syndrome Type I

1Center for Pain Medicine, Erasmus MC, University Medical Center, Postbus 2040, 3000 CA Rotterdam, Netherlands
2Department of Immunology, Erasmus MC, University Medical Center, Postbus 2040, 3000 CA Rotterdam, Netherlands

Received 27 September 2014; Revised 25 January 2015; Accepted 26 January 2015

Academic Editor: Dianne Cooper

Copyright © 2015 Maaike Dirckx et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. de Mos, M. C. J. M. Sturkenboom, and F. J. P. M. Huygen, “Current understandings on complex regional pain syndrome,” Pain Practice, vol. 9, no. 2, pp. 86–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. H. J. M. Veldman, H. M. Reynen, I. E. Arntz, and R. J. A. Goris, “Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients,” The Lancet, vol. 342, no. 8878, pp. 1012–1016, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. F. J. P. M. Huygen, A. G. J. de Bruijn, M. T. de Bruin, J. G. Groeneweg, J. Klein, and F. J. Zijlstra, “Evidence for local inflammation in complex regional pain syndrome type 1,” Mediators of Inflammation, vol. 11, no. 1, pp. 47–51, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Wesseldijk, F. J. Huygen, C. Heijmans-Antonissen, S. P. Niehof, and F. J. Zijlstra, “Tumor necrosis factor-α and interleukin-6 are not correlated with the characteristics of Complex Regional Pain Syndrome type 1 in 66 patients,” European Journal of Pain, vol. 12, no. 6, pp. 716–721, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Dirckx, D. L. Stronks, G. Groeneweg, and F. J. P. M. Huygen, “Effect of immunomodulating medications in complex regional pain syndrome: a systematic review,” Clinical Journal of Pain, vol. 28, no. 4, pp. 355–363, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. M. de Mos, A. G. J. de Bruijn, F. J. P. M. Huygen, J. P. Dieleman, B. H. C. Stricker, and M. C. J. M. Sturkenboom, “The incidence of complex regional pain syndrome: a population-based study,” Pain, vol. 129, no. 1-2, pp. 12–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Mailis and J. Wade, “Profile of Caucasian women with possible genetic predisposition to reflex sympathetic dystrophy: a pilot study,” The Clinical Journal of Pain, vol. 10, no. 3, pp. 210–217, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Kemler, A. C. van de Vusse, E. M. van den Berg-Loonen, G. A. M. Barendse, M. van Kleef, and W. E. J. Weber, “HLA-DQ1 associated with reflex sympathetic dystrophy,” Neurology, vol. 53, no. 6, pp. 1350–1351, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. de Rooij, M. Florencia Gosso, G. W. Haasnoot et al., “HLA-B62 and HLA-DQ8 are associated with complex regional pain syndrome with fixed dystonia,” Pain, vol. 145, no. 1-2, pp. 82–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. de Mos, F. J. P. M. Huygen, J. P. Dieleman, J. S. H. A. Koopman, B. H. C. Stricker, and M. C. J. M. Sturkenboom, “Medical history and the onset of complex regional pain syndrome (CRPS),” Pain, vol. 139, no. 2, pp. 458–466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Schwartzman, C. Gurusinghe, and E. Gracely, “Prevalence of complex regional pain syndrome in a cohort of multiple sclerosis patients,” Pain Physician, vol. 11, no. 2, pp. 133–136, 2008. View at Google Scholar · View at Scopus
  12. A. Goebel, H. Vogel, O. Caneris et al., “Immune responses to campylobacter and serum autoantibodies in patients with complex regional pain syndrome,” Journal of Neuroimmunology, vol. 162, no. 1-2, pp. 184–189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. C. van de Vusse, V. J. Goossens, M. A. Kemler, and W. E. J. Weber, “Screening of patients with complex regional pain syndrome for antecedent infections,” The Clinical Journal of Pain, vol. 17, no. 2, pp. 110–114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Gross, M. Tschernatsch, M. E. Bräu et al., “Increased seroprevalence of parvovirus B 19 IgG in complex regional pain syndrome is not associated with antiendothelial autoimmunity,” European Journal of Pain, vol. 11, no. 2, pp. 237–240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Blaes, K. Schmitz, M. Tschernatsch et al., “Autoimmune etiology of complex regional pain syndrome (M. Sudeck),” Neurology, vol. 63, no. 9, pp. 1734–1736, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Kohr, M. Tschernatsch, K. Schmitz et al., “Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen,” Pain, vol. 143, no. 3, pp. 246–251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Goebel, M. I. Leite, L. Yang et al., “The passive transfer of immunoglobulin G serum antibodies from patients with longstanding complex regional pain syndrome,” European Journal of Pain, vol. 15, no. 5, pp. 504.e1–504.e6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Goebel, A. Baranowski, K. Maurer, A. Ghiai, C. McCabe, and G. Ambler, “Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial,” Annals of Internal Medicine, vol. 152, no. 3, pp. 152–158, 2010. View at Google Scholar · View at Scopus
  19. A. Goebel and F. Blaes, “Complex regional pain syndrome, prototype of a novel kind of autoimmune disease,” Autoimmunity Reviews, vol. 12, no. 6, pp. 682–686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. R. J. T. Smeenk, “Antinuclear antibodies: cause of disease or caused by disease?” Rheumatology, vol. 39, no. 6, pp. 581–584, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Hooijkaas, R. Smeenk, and F. Gmelig Meyling, “Systemic autoimmune diseases: appropriate serological diagnostics,” Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, vol. 31, no. 4, pp. 257–268, 2006. View at Google Scholar · View at Scopus
  22. E. Lancaster and J. Dalmau, “Neuronal autoantigens—pathogenesis, associated disorders and antibody testing,” Nature Reviews Neurology, vol. 8, no. 7, pp. 380–390, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Bruehl, R. N. Harden, B. S. Galer et al., “External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria,” Pain, vol. 81, no. 1-2, pp. 147–154, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Agmon-Levin, J. Damoiseaux, C. Kallenberg et al., “International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies,” Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 17–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. J. W. B. Moll, J. C. Antoine, H. R. Brashear et al., “Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the workshop to the fourth meeting of the international society of neuro-immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, the Netherlands,” Neurology, vol. 45, no. 10, pp. 1937–1941, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. D. S. Pisetsky, “Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg?” Arthritis Research and Therapy, vol. 13, no. 2, article 109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. S. Wiik, M. Høier-Madsen, J. Forslid, P. Charles, and J. Meyrowitsch, “Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells,” Journal of Autoimmunity, vol. 35, no. 3, pp. 276–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. A. R. Karim, R. G. Hughes, J. B. Winer, A. C. Williams, and A. R. Bradwell, “Paraneoplastic neurological antibodies: a laboratory experience,” Annals of the New York Academy of Sciences, vol. 1050, pp. 274–285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Tsutsumi, T. Horita, J. Ohmuro et al., “Reflex sympathetic dystrophy in a patient with the antiphospholipid syndrome,” Lupus, vol. 8, no. 6, pp. 471–473, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. B. E. Ostrov, A. H. Eichenfield, D. P. Goldsmith, and H. R. Schumacher, “Recurrent reflex sympathetic dystrophy as a manifestation of systemic lupus erythematosus,” The Journal of Rheumatology, vol. 20, no. 10, pp. 1774–1776, 1993. View at Google Scholar · View at Scopus
  31. A. L. Oaklander and H. L. Fields, “Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy?” Annals of Neurology, vol. 65, no. 6, pp. 629–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhang and P. Popovich, “Roles of autoantibodies in central nervous system injury,” Discovery medicine, vol. 11, no. 60, pp. 395–402, 2011. View at Google Scholar · View at Scopus
  33. C. Sommer, “Anti-autonomic nervous system antibodies in CRPS,” Pain, vol. 152, no. 12, pp. 2675–2676, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Goebel, M. Stock, R. Deacon, G. Sprotte, and A. Vincent, “Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1,” Annals of Neurology, vol. 57, no. 3, pp. 463–464, 2005. View at Publisher · View at Google Scholar · View at Scopus